Zoetis Inc

NYSE:ZTS

Ms. Kristin C. Peck

CEO & Director

Kristin C. Peck is the Chief Executive Officer of Zoetis Inc., a leading global animal health company. She was appointed CEO in January 2020, succeeding Juan Ramón Alaix. Before becoming CEO, Peck served as Executive Vice President and Group President of U.S. Operations, Business Development, and Strategy at Zoetis. She has played a significant role in shaping the company's strategic direction and growth, focusing on innovation and customer service. Before her tenure at Zoetis, Peck worked at Pfizer, where Zoetis originated as a business unit. Her experience there included roles in corporate strategy and business development. Peck also has experience in management consulting, having worked for Boston Consulting Group earlier in her career. She holds an MBA from Columbia Business School and a bachelor's degree from Georgetown University. Under her leadership, Zoetis has continued to focus on new product development and expanding its market presence, maintaining its status as a leader in the animal health industry. Peck is also known for promoting diversity and inclusion within the company, as well as sustainability initiatives.

Mr. Wetteny N. Joseph CPA

Executive VP & CFO

Wetteny N. Joseph is a notable figure in the pharmaceutical industry, particularly known for his role at Zoetis Inc., where he serves as the Executive Vice President and Chief Financial Officer (CFO). Before his tenure at Zoetis, he gained extensive experience in financial leadership and strategic roles across various sectors. Joseph holds the designation of a Certified Public Accountant (CPA) and has built a reputation for his expertise in financial management, strategic planning, and operational execution. His career includes significant leadership positions at Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. At Catalent, he served as Senior Vice President & Chief Financial Officer, where he played a key role in driving the company’s financial strategy and growth initiatives. Throughout his career, Joseph has been recognized for his ability to lead complex financial operations and contribute to business development strategies that drive profitability and efficiency. His leadership style is marked by a focus on fostering cross-functional teamwork and leveraging financial insights to support corporate objectives. Educationally, Wetteny Joseph has a strong background in accounting and finance, which has underpinned his successful career trajectory. His contributions continue to be instrumental in the financial stewardship and strategic direction of Zoetis Inc., a global leader in animal health.

Wafaa Mamilli is an accomplished business executive known for her role as the Executive Vice President and Chief Information and Digital Officer at Zoetis Inc. In her capacity, Ms. Mamilli is responsible for leading Zoetis's global technology and digital strategy, ensuring that the company's digital transformation efforts align with its business objectives and enhance operational efficiency. Before joining Zoetis, Wafaa served in various leadership roles, notably working with Eli Lilly and Company, where she gained substantial experience in IT and digital leadership. Her career is marked by a strong focus on leveraging technology to drive innovation in the healthcare and life sciences sectors. Ms. Mamilli holds a bachelor's degree in engineering from Ecole Nationale Supérieure des Télécommunications in France and a Master of Business Administration from INSEAD. Her educational background, combined with her extensive professional experience, has enabled her to effectively lead digital initiatives and deliver value to the organizations she serves. At Zoetis, she is instrumental in advancing the integration of digital tools and platforms to optimize the company's operations, engage customers, and support the development of animal health solutions.

Dr. Robert J. Polzer, Ph.D., is a recognized leader in the pharmaceutical and animal health industry, currently serving as the Executive Vice President and President of Research and Development at Zoetis Inc. With an extensive background in the field, Dr. Polzer oversees Zoetis's research and development efforts, guiding the strategic direction of innovative solutions aimed at enhancing animal health. Before joining Zoetis, Dr. Polzer built a robust career at Pfizer, Inc., where he held various roles of increasing responsibility, particularly focused on drug metabolism and pharmacokinetics. He played a significant role in advancing Pfizer's research initiatives, contributing to the development of several key therapeutics. Dr. Polzer holds a doctoral degree in pharmaceutical sciences, which underlines his deep expertise in pharmaceuticals and veterinary medicine. His leadership at Zoetis is crucial in maintaining the company's position as a global leader in the development of medicines, vaccines, and diagnostic products for both livestock and companion animals. Under his stewardship, Zoetis continues to focus on innovation and sustainability, ensuring the health and wellness of animals worldwide are prioritized through science-driven solutions.

Keith Sarbaugh is a recognized executive at Zoetis Inc., where he serves as Executive Vice President and Group President of Global Manufacturing and Supply (GMS) and Global Biologicals. With extensive experience spanning over three decades in production and global supply chain management, Sarbaugh has significantly contributed to the company's operations and strategic initiatives. Prior to joining Zoetis, he held various leadership roles at Pfizer, where he was instrumental in improving manufacturing processes and ensuring efficient supply chain management. His expertise has been crucial in overseeing the manufacturing and supply of animal health products globally, positioning Zoetis as a leader in the industry. Sarbaugh is known for his comprehensive approach to operational excellence and his commitment to quality, safety, and sustainability in manufacturing processes.

Mr. Steven Frank

Vice President of Investor Relations

As of the latest available information, Stephen L. Frank serves as the Executive Vice President and Chief Financial Officer at Zoetis Inc. In his role, Frank is responsible for overseeing the company's global financial operations, including financial planning, investor relations, accounting, tax, and treasury, as well as procurement. Since joining Zoetis, a leading animal health company, Frank has been pivotal in steering the company toward achieving its financial objectives and contributing to its strategic growth and operational efficiencies. Under his financial leadership, Zoetis continues to strengthen its market position and deliver value to stakeholders by maintaining a strong balance sheet and optimizing financial performance. Before assuming his role at Zoetis, Frank gained extensive experience in the financial sector, holding senior financial positions at other prominent organizations, where he developed a solid reputation for his financial acumen and leadership capabilities. His professional background is marked by a track record of successfully leading finance teams and driving corporate initiatives that align financial and business strategies. Stephen Frank is known for his strategic mindset and thorough understanding of the complexities within the global financial landscape, which has been instrumental in guiding Zoetis through various economic cycles and industry dynamics.

Roxanne Lagano is the Executive Vice President, Chief Financial Officer, and Executive Vice President of Business Development and Strategy at Zoetis Inc., a leading global animal health company. In her role, she oversees the company’s financial operations, including accounting, investor relations, tax, treasury, and audit. She is also responsible for strategic planning and business development initiatives, guiding the company's growth strategies. Roxanne has been instrumental in driving financial performance and strategic decision-making at Zoetis, contributing to the company's ongoing success in the animal health industry. Before joining Zoetis, she worked at Pfizer Inc., where she held various senior financial roles, acquiring substantial experience in finance and strategic business development. Roxanne Lagano's leadership has been characterized by a focus on financial discipline, strategic growth, and innovation, helping Zoetis maintain its position as a leader in the field of animal health. Her extensive experience and expertise in the pharmaceutical and animal health industries have made her a key figure at Zoetis.

Mr. William Price

VP & Chief Communications Officer

William F. Price is the Executive Vice President and Chief Financial Officer (CFO) at Zoetis Inc., a prominent global animal health company. He is responsible for overseeing the company's financial operations, including financial planning and analysis, investor relations, tax, treasury, and internal audit functions. Prior to his role at Zoetis, Price garnered extensive experience in finance and leadership positions. Before joining Zoetis, he served as CFO for various divisions within Pfizer, contributing significantly to their financial strategies and operations. His strong background in the pharmaceutical industry through these engagements provided him with the expertise needed in a sector closely aligned with Zoetis's operations. William Price holds a Bachelor's degree in Finance and an MBA, equipping him with a solid educational foundation that supports his role as a financial leader. His leadership is characterized by a focus on operational efficiency and strategic growth, aligning with Zoetis’s mission to deliver high-quality products and services in animal health.

Julie A. Fuller is an accomplished executive at Zoetis Inc., a global leader in animal health. She serves as the Executive Vice President and Chief Human Resources Officer. In this role, Fuller is responsible for overseeing the company's human resources strategy, fostering a dynamic and inclusive workplace environment, and ensuring alignment of the HR function with the company's overall mission and goals. She brings a wealth of experience in human resources leadership and strategic management to her position, having held significant roles in talent management and organizational development in other organizations before joining Zoetis. Under her leadership, Zoetis continues to cultivate a culture that supports innovation, collaboration, and employee development.

Jeannette Ferran Astorga is a recognized leader with significant expertise in corporate responsibility and sustainability. She serves as the Executive Vice President of Corporate Affairs, Communications, and Sustainability at Zoetis Inc., the world-leading animal health company. In her role, Ms. Ferran Astorga is responsible for overseeing the company’s efforts in corporate affairs and communications, spearheading strategies that enhance Zoetis' reputation, and engaging stakeholders effectively. She plays a crucial part in aligning the company's sustainability goals with its business strategy, driving initiatives that promote sustainable practices across the company's operations. Prior to joining Zoetis, Ms. Ferran Astorga had an impactful career at various other global organizations where she honed her skills in sustainability leadership, corporate citizenship, and effective communication strategies. Her extensive experience contributes to Zoetis' commitment to sustainable development and its efforts to address the social and environmental impacts of its operations. Throughout her career, she has been recognized for her ability to integrate corporate responsibility into core business strategy, enhancing the long-term value for companies and their stakeholders. Her leadership is key in making Zoetis an industry leader not just in animal health but also in corporate responsibility.